Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
Create a free accountThis page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Galera Therapeutics, Inc.Security delisted | Buy | $10.5K | conv 38First in 12mo | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $126.8K | conv 40First in 12mo | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $18.9K | conv 17 | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $849 | conv 17 | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $109K | conv 40First in 12mo | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $10.5K | conv 38First in 12mo | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $40.9 | conv 17 | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $14.8K | conv 17 | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $19K | conv 38First in 12mo | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $59.7 | conv 17 | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $19 | conv 17 | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $11.9K | conv 38First in 12mo | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $13.7K | conv 38First in 12mo | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $3.3K | conv 17 | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $53.5K | conv 39First in 12mo | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $868.4 | conv 17 | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $60.4K | conv 37First in 12mo | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $48.2K | conv 39First in 12mo | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $19K | conv 17 | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $20K | conv 17 | SEC | |
Galera Therapeutics, Inc.Security delisted | Buy | $49.5K | conv 18 | SEC |